Page 7 - தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் Today - Breaking & Trending Today

Investegate |Basilea Pharmaceutica AG Announcements | Basilea Pharmaceutica AG: Basilea announces divestment of its Chinese R&D subsidiary to PHT International

Basilea announces divestment of its Chinese R&D subsidiary to PHT International
Basel, Switzerland, February 15, 2021
Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into an agreement to divest its Chinese research and development (R&D) subsidiary Basilea Pharmaceutica China Ltd. (“BPC”), by selling BPC’s parent company BPh Investitionen Ltd. to the U.S.-based custom manufacturing organization PHT International Inc. (“PHT”). This will increase flexibility in sourcing R&D services in the future. All 72 employees and the facilities will be transferred to PHT. The initial payment is USD 2.5 million, which will be due upon closing of the transaction, which is expected in the second quarter of 2021 subject to customary closing conditions. Basilea is entitled to additional payments of USD 3.8 million over the course of the next three years, for a total purchase price of USD 6.3 million. ....

North Carolina , United States , Basel Stadt , Nils Schr , David Veitch , Laurenz Kellenberger , Bph Investitionen Ltd , Technological Development Zone Of Nantong , Head Of Corporate Communications Investor Relations , Swiss Exchange , Basilea Pharmaceutica Ltd , International Inc , Basilea Pharmaceutica China Ltd , Basilea Pharmaceutica China , Chief Executive Officer , Chief Scientific Officer , Pharmaceutica China , Haimen Economic Technological Development Zone , Basilea Pharmaceutica , Corporate Communications , Investor Relations , Investegate Announcements , Investegate Company Announcements , Basilea Pharmaceutica Ag , Globe Newswire , Globenewswire And ,

Basilea announces divestment of its Chinese R&D subsidiary to PHT International

Basel, Switzerland, February 15, 2021
Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into an agreement to divest its Chinese research and development (R&D) subsidiary Basilea Pharmaceutica China Ltd. (“BPC”), by selling BPC’s parent company BPh Investitionen Ltd. to the U.S.-based custom manufacturing organization PHT International Inc. (“PHT”). This will increase flexibility in sourcing R&D services in the future. All 72 employees and the facilities will be transferred to PHT. The initial payment is USD 2.5 million, which will be due upon closing of the transaction, which is expected in the second quarter of 2021 subject to customary closing conditions. Basilea is entitled to additional payments of USD 3.8 million over the course of the next three years, for a total purchase price of USD 6.3 million. ....

North Carolina , United States , Basel Stadt , Nils Schr , David Veitch , Laurenz Kellenberger , Bph Investitionen Ltd , Technological Development Zone Of Nantong , Head Of Corporate Communications Investor Relations , Swiss Exchange , Basilea Pharmaceutica Ltd , International Inc , Basilea Pharmaceutica China Ltd , Basilea Pharmaceutica China , Chief Executive Officer , Chief Scientific Officer , Pharmaceutica China , Haimen Economic Technological Development Zone , Basilea Pharmaceutica , Corporate Communications , Investor Relations , Swiss Stock Exchange Bsln , Basilea Pharmaceutica Ag , வடக்கு கரோலினா , ஒன்றுபட்டது மாநிலங்களில் , பேசல் ஸ்ட்யாட்ட் ,

Basilea reports positive topline results from phase 2 study FIDES-01 for derazantinib in FGFR2 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , Basel Stadt , Nils Schr , Marc Engelhardt , Merck Co Inc , Head Of Corporate Communications Investor Relations , Arqule Inc , Basilea Pharmaceutica Ltd , Swiss Exchange , Chief Medical Officer , Basilea Pharmaceutica , Corporate Communications , Western Europe , Product Testing , Diagnosis And Treatment , Globe Newswire , Pharmaceutical Manufacturing , Health Care Industry , Products And Services , Medical Research , Clinical Trials , Corporate News , North America , Diseases And Conditions , Liver Disease , ஒன்றுபட்டது மாநிலங்களில் ,

Basilea reports preliminary 2020 revenue and portfolio progress

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

Basel Stadt , Nils Schr , Marc Engelhardt , Asahi Kasei Pharma , David Veitch , Adesh Kaul , Head Of Corporate Communications Investor Relations , Virtual Congress , Basilea Pharmaceutica Ltd , Swiss Exchange , Chief Executive Officer , Chief Financial Officer , Chief Medical Officer , Basilea Pharmaceutica , Corporate Communications , Medical Research , Corporate News , Pharmaceutical Manufacturing , Health Care Industry , Lung Disease , Clinical Trials , Coronavirus Pandemic , Western Europe , Product Testing , Diseases And Conditions , Infectious Diseases ,

Basilea Pharmaceutica AG: Basilea reports preliminary 2020 revenue and portfolio progress

Significant progress made in the commercialization of Cresemba and Zevtera with 2020 revenue contributions of CHF 112 million in line with guidanceAdvancement in the FIDES clinical program with derazantinibCHF ....

Basel Stadt , Nils Schr , Marc Engelhardt , Asahi Kasei Pharma , David Veitch , Adesh Kaul , Merck Co Inc , Head Of Corporate Communications Investor Relations , Virtual Congress , Arqule Inc , Swiss Exchange , Basilea Pharmaceutica Ltd , Chief Executive Officer , Chief Financial Officer , Chief Medical Officer , Basilea Pharmaceutica , Corporate Communications , பேசல் ஸ்ட்யாட்ட் , டேவிட் வைச் , மெர்க் இணை இன்க் , தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் , மெய்நிகர் காங்கிரஸ் , சுவிஸ் பரிமாற்றம் , தலைமை நிர்வாகி அதிகாரி , தலைமை நிதி அதிகாரி , தலைமை மருத்துவ அதிகாரி ,